These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 21739425

  • 21. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
    Chen J, Sun S, Yan Q, Bao C, Fu Q.
    Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
    [Abstract] [Full Text] [Related]

  • 22. Antiphospholipid Syndrome and the Kidney.
    Sciascia S, Baldovino S, Schreiber K, Solfietti L, Roccatello D.
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [Abstract] [Full Text] [Related]

  • 23. Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus.
    Broder A, Putterman C.
    J Rheumatol; 2013 Jan; 40(1):30-3. PubMed ID: 22859353
    [Abstract] [Full Text] [Related]

  • 24. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM, Patrushev LI, Stukacheva EA, Miroshnikov AI, Tikhonova TL, Nasonov EL, Alekberova ZS.
    Ter Arkh; 2000 Jan; 72(5):34-8. PubMed ID: 11109617
    [Abstract] [Full Text] [Related]

  • 25. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
    Ghirardello A, Doria A, Ruffatti A, Rigoli AM, Vesco P, Calligaro A, Gambari PF.
    Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460
    [Abstract] [Full Text] [Related]

  • 26. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 27. Antiphospholipid antibodies in systemic lupus erythematosus and the antiphospholipid syndrome.
    Setty YN, Komatireddy GR.
    Front Biosci; 2001 Dec 01; 6():E207-12. PubMed ID: 11724683
    [Abstract] [Full Text] [Related]

  • 28. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L, Chighizola CB, Nalli C, Gerosa M, Borghi MO, Pregnolato F, Grossi C, Zanola A, Allegri F, Norman GL, Mahler M, Meroni PL, Tincani A.
    Arthritis Rheumatol; 2015 May 01; 67(8):2196-204. PubMed ID: 25939498
    [Abstract] [Full Text] [Related]

  • 29. Antiphospholipid antibody-induced cellular responses depend on epitope specificity : implications for treatment of antiphospholipid syndrome.
    Müller-Calleja N, Hollerbach A, Häuser F, Canisius A, Orning C, Lackner KJ.
    J Thromb Haemost; 2017 Dec 01; 15(12):2367-2376. PubMed ID: 29024318
    [Abstract] [Full Text] [Related]

  • 30. Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome.
    Müller-Calleja N, Köhler A, Siebald B, Canisius A, Orning C, Radsak M, Stein P, Mönnikes R, Lackner KJ.
    Thromb Haemost; 2015 May 01; 113(5):1071-83. PubMed ID: 25589411
    [Abstract] [Full Text] [Related]

  • 31. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.
    Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, Núñez-Álvarez C, Hernández-Ramírez D, Bockenstedt PL, Liaw PC, Cabral AR, Knight JS.
    Arthritis Rheumatol; 2015 Nov 01; 67(11):2990-3003. PubMed ID: 26097119
    [Abstract] [Full Text] [Related]

  • 32. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T, Kaczor MP, Celińska-Löwenhoff M, Polański S, Musiał J.
    Thromb Res; 2017 May 01; 153():90-94. PubMed ID: 28363116
    [Abstract] [Full Text] [Related]

  • 33. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep 01; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 34. Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus.
    Marchetti T, Ribi C, Perneger T, Trendelenburg M, Huynh-Do U, de Moerloose P, Chizzolini C.
    Rheumatology (Oxford); 2018 Aug 01; 57(8):1350-1357. PubMed ID: 29672737
    [Abstract] [Full Text] [Related]

  • 35. Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.
    Yang YH, Hwang KK, FitzGerald J, Grossman JM, Taylor M, Hahn BH, Chen PP.
    J Immunol; 2006 Dec 01; 177(11):8219-25. PubMed ID: 17114499
    [Abstract] [Full Text] [Related]

  • 36. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin.
    Yang CD, Hwang KK, Yan W, Gallagher K, FitzGerald J, Grossman JM, Hahn BH, Chen PP.
    J Immunol; 2004 May 01; 172(9):5765-73. PubMed ID: 15100323
    [Abstract] [Full Text] [Related]

  • 37. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
    Fischer K, Brzosko M, Walecka A, Ostanek L, Sawicki M.
    Pol Arch Med Wewn; 2007 May 01; 117 Suppl():13-7. PubMed ID: 18778013
    [Abstract] [Full Text] [Related]

  • 38. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies.
    Pierangeli SS, Vega-Ostertag ME, Raschi E, Liu X, Romay-Penabad Z, De Micheli V, Galli M, Moia M, Tincani A, Borghi MO, Nguyen-Oghalai T, Meroni PL.
    Ann Rheum Dis; 2007 Oct 01; 66(10):1327-33. PubMed ID: 17261530
    [Abstract] [Full Text] [Related]

  • 39. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S, Regnault V, Guillemin F, Kaminsky P, Rat AC, Lecompte T, Wahl D.
    Thromb Res; 2013 Jul 01; 132(1):e1-7. PubMed ID: 23676348
    [Abstract] [Full Text] [Related]

  • 40. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM.
    J Autoimmun; 1999 Nov 01; 13(3):347-55. PubMed ID: 10550222
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.